Ocugen, Inc. (OCGN)
0.9169
-0.06
(-6.19%)
USD |
NASDAQ |
Oct 09, 14:30
Ocugen 30-Day Average Daily Volume : 7.788M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 7.788M |
| October 07, 2026 | 7.455M |
| October 06, 2026 | 7.434M |
| October 05, 2026 | 7.354M |
| October 02, 2026 | 7.252M |
| October 01, 2026 | 7.269M |
| September 30, 2026 | 7.330M |
| September 29, 2026 | 7.170M |
| September 28, 2026 | 7.001M |
| September 25, 2026 | 6.939M |
| September 24, 2026 | 6.780M |
| September 23, 2026 | 6.698M |
| September 22, 2026 | 6.375M |
| September 21, 2026 | 6.312M |
| September 18, 2026 | 6.324M |
| September 17, 2026 | 6.018M |
| September 16, 2026 | 6.097M |
| September 15, 2026 | 6.013M |
| September 14, 2026 | 5.709M |
| September 11, 2026 | 5.625M |
| September 10, 2026 | 5.526M |
| September 09, 2026 | 5.017M |
| September 08, 2026 | 3.871M |
| September 04, 2026 | 3.945M |
| September 03, 2026 | 3.964M |
| Date | Value |
|---|---|
| September 02, 2026 | 3.993M |
| September 01, 2026 | 3.960M |
| August 31, 2026 | 4.144M |
| August 28, 2026 | 4.143M |
| August 27, 2026 | 4.167M |
| August 26, 2026 | 4.237M |
| August 25, 2026 | 4.289M |
| August 24, 2026 | 4.302M |
| August 21, 2026 | 4.390M |
| August 20, 2026 | 4.426M |
| August 19, 2026 | 4.476M |
| August 18, 2026 | 4.499M |
| August 17, 2026 | 4.573M |
| August 14, 2026 | 4.672M |
| August 13, 2026 | 4.805M |
| August 12, 2026 | 4.868M |
| August 11, 2026 | 5.143M |
| August 10, 2026 | 5.536M |
| August 07, 2026 | 7.310M |
| August 06, 2026 | 7.351M |
| August 05, 2026 | 7.384M |
| August 04, 2026 | 7.448M |
| August 03, 2026 | 7.437M |
| July 31, 2026 | 8.194M |
| July 30, 2026 | 8.267M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.086M |
| Gilead Sciences, Inc. | 5.591M |
| MannKind Corp. | 4.541M |
| Nektar Therapeutics | 1.542M |
| Vertex Pharmaceuticals, Inc. | 1.013M |